FDA Approves Drug Cocktail To Treat Mesothelioma
It's the first regimen approved for that type of lung cancer in 16 years.
Drug Combo To Treat Mesothelioma Approved By FDA
The U.S. Food and Drug Administration on Friday announced approval for a drug combo to treat malignant pleural mesothelioma, a cancer associated with inhalation of asbestos fibers. According to the federal agency, Opdivo (nivolumab) along with Yervoy (ipilimumab) marks the first regimen approved for mesothelioma in 16 years. (Rivas, 10/5)
Bristol Myers Squibb To Buy MyoKardia For $13 Billion
Bristol Myers Squibb said that it will purchase MyoKardia, an 8-year-old developer of an experimental heart drug, for $13.1 billion in cash. The deal price, at $225 per MyoKardia share, represents a 61% premium to the closing price of MyoKardia shares on Friday. (Herper, 10/5)
FDA Issues Rare Emergency Authorization For AI Tool For Covid-19 Care
In less than a year, the pandemic has spurred the development of countless artificial intelligence models designed to aid in the diagnosis of Covid-19 and spot early warning signs of severe illness among those infected. But so far, only a few have received emergency use authorization from the Food and Drug Administration. That scarcity is a sign of the newness of these tools — as well as the murkiness of the regulatory landscape at a time when unapproved algorithms are being widely tested and rolled out in the clinic. (Robbins, 10/5)